BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SAPA-GP - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SAPA-GP
X-ORIGINAL-URL:https://sapagp.org
X-WR-CALDESC:Events for SAPA-GP
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220415T120000
DTEND;TZID=America/New_York:20220416T190000
DTSTAMP:20260423T195348
CREATED:20220314T012254Z
LAST-MODIFIED:20220911T023850Z
UID:3622-1650024000-1650135600@sapagp.org
SUMMARY:Turbo Charging Innovation in the New Decade of Life Sciences --- US-China Biopharma Congress - SAPA-GP 2022 Annual Conference (Hybrid)
DESCRIPTION:Turbo Charging Innovation in the New Decade of Life Sciences  Sheraton Valley Forge Hotel\n480 N Gulph Rd\, King of Prussia\, PA 19406\nor\nthrough Online Platform and Mobile App \nRegister Here中国地区平台注册AgendaProgram Brochure As the flagship event of SAPA-GP\, our Annual Conference attracted over 1\,000 attendees each year\, featuring presentations and panel discussions by distinguished speakers and panelists from academia\, industry\, and regulatory authorities\, to provide opportunities for scientific exchange\, public health education\, networking\, career development\, and business collaborations. After two years of postponement due to the pandemic situation\, we have decided that it is time to host the annual conference again\, through a hybrid platform\, which allows for both local participants to enjoy the social networking again\, and global participants to connect from all over the world without geographic restrictions. You can join us from Anywhere!\n\n1 week final count down! Register now or onsite. \n3 Parallel Tracks:\n\nScientific track: Redefining pharmaceutical innovation from bench to bedside\nBusiness track: Unleashing the power from scientific breakthroughs and entrepreneurship (Co-branding with BioKatalyst)\nCareer track: Preparing life scientists for the future\n\n\nAgenda and Speakers Highlights below:\n\nFor detailed Agenda\, please check here or click on the Agenda Tab.\n\nEnjoy the benefits of Hybrid Platform: \nOnline: \n\n\nAccess to mobile app for program navigation and live stream of all presentations.\nSchedule 1-1 meetings with all attendees including sponsors through mobile app and online platform.\nRandom matchmaking and speed networking\n1 month access to cloud recording of presentation videos\n\nOnsite:\n\nAll benefits from online\nFood & beverage included (worth $80/person)\nFriday: Snack Bar (4-5pm)\, free coffee\nSaturday: Lunch box (11:30 am-12:30pm) & Snack Bar (4-5pm)\, free coffee\nAttend company show cases and opportunities of direct contact/mock interview with hiring manager from 10+ prestigious pharmaceutical companies.\nSocial networking with speakers and other attendees from pharmaceutical industry\nAttend career development workshops and join 1-1 SAPA-GP mentoring program\n\nSponsors
URL:https://sapagp.org/event/turbo-charging-innovation-in-the-new-decade-of-life-sciences-us-china-biopharma-congress-sapa-gp-2022-annual-conference-hybrid/
LOCATION:Sheraton Valley Forge Hotel\, 480 North Gulph Road\, King of Prussia\, PA\, 19406\, United States
CATEGORIES:AC,Event
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2022/03/AC2022.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210715T200000
DTEND;TZID=America/New_York:20210715T213000
DTSTAMP:20260423T195348
CREATED:20210702T001923Z
LAST-MODIFIED:20221201T192628Z
UID:3502-1626379200-1626384600@sapagp.org
SUMMARY:Cell & Gene Therapy (CGT) Rapid Growth in China: What Could be Your Share of the Pie?
DESCRIPTION:Register HereSpeakers:Amit AgarwalManaging Director\, Life Sciences San Francisco\, CA Amit is a Managing Director in Deloitte Consulting’s Life Sciences practice. Amit has more than 25 years of management consulting experience and has led multiple projects in both strategy and operations Amit co-leads the Next Generation Therapies practice. The practice focuses on advising clients on taking advantage of and/or developing strategic responses to new disruptive technologies in cell and gene therapies space. Amit has worked with Life Science clients in the U.S. Europe and Asia on high-impact projects.\nAmit also has experience as Vice President at Leerink Swann & Co.\, a boutique investment bank focused on the life sciences. He helped innovative life science companies raise capital\, identify merger and acquisition targets and negotiate strategic partnerships and alliances. He helped his clients generate nearly $1 billion of market value through the deals he helped broker.\nAmit publishes extensively in the business press and in peer reviewed academic journals on personalized medicine. Amit has presented at multiple conferences in North America\, South America and Europe and worked with industry associations on value-based care and risk sharing contracts in light of new technology paradigms.\nAmit holds an MBA in finance and technological innovation from the MIT Sloan School of Management and a bachelor’s degree in history and premed from Occidental College. Prior to business school\, Amit conducted research in neurobiology at the California Institute ofTechnology and was an American diplomat posted in China and the Middle East. Annie XuSpecialist Leader\, Life Sciences and Health Care\, Deloitte Consulting\, USAI am a core member of Deloitte’s NextGen Practice\, with a focus on helping cell and gene companies set up their supply chain and commercial platform to launch their products globally. I co-lead Deloitte’s Industry Working Group (IWG)\, working closely with industry leaders to design patient-centric solutions that provide CGT access to a broader patient population.\nRelevant experiences:\n1. Developed a digital strategy to support the first gene-editing product launch in the US and EMEA\n2. Performed the market landscape assessment for cell and gene therapies and developed the investment strategy for a PE firm\n3. Led patient journey development and market sizing for an ultra-rare disease gene therapy\, and develop launch strategy in Saudi\, Russia\, Japan\, and Brazil\nSupported commercial site certification across 80+ hospitals within the US for a CAR-T product\n4. Drove the global launch readiness for the most expensive gene therapy product outside of the US\, with a projected $1B sales revenue in 2020David Xie\, PhDPartner\, NextGen expertI’m a Partner based in Shanghai\, China with a focus on biotech and next generation therapies practice. We often take a China specific view and help clients to understand the intricate and fast-evolving policies environment and what it means for entry strategy\, regulatory path\, market access\, and go-to-market models. We also tackle next-generation specific issues such as site certification and supply chain visibility. My experience in CGT:\n1. Led multiple projects with leading overseas biopharma companies to help define China product regulatory paths\, market access and GTMs including CAR-T\, targeted oncology drugs\, and rare disease drugs\n2. Worked on global supply chain and China commercial excellence to define China entry and supply chain models for Cell & Gene Therapies\n3. Worked on the launch of multiple CAR-T products access and pricing strategy in China\n4. Worked on the companion genetic diagnosis tests clinical development and GTM assessment as part of the CGT product portfolio\n5. Represent the Deloitte Next Generation Therapies practice in China with thought leadership on driving In China For China business modelsJohn Law Strategy and Business Design Manager\, Deloitte Consulting\, ChinaJohn is a Shanghai based Manager at the Strategy & Business Design service\nline\, also known as Monitor Deloitte and now part of Strategy\, Analytics and M&A offering portfolio\, of Deloitte Consulting. He studied Biomedical Sciences at University of Oxford where he specialized in scientific data analysis as well as experimental testing; through which he developed a research oriented and data driven approach to solving problems.\nJohn possesses a diverse skill set from strategy to operations in Life Sciences\nand Health Care consulting. His strong written and verbal communication skills also contributed to his successful track record in interacting with clients across levels. John is fluent in English\, Mandarin Chinese and Cantonese Chinese.\nSelected project experience:\n• Assessed China competitive landscape as well as pricing and reimbursement environment for a leading British multinational pharmaco’s hepatocellular carcinoma CAR T; designed likely market access journey for client’s CAR T by formulating various reimbursement scenarios and price volume relationship\n• Evaluated China go to market model options for a leading Japanese multinational pharmco’s portfolio of gene therapies having identified relevant regulatory barriers; designed entry roadmap from entity set up\, clinical trials\, product and materials import to commercialization\n• Estimated China market size and attractiveness for a leading Japanese multinational medical device company’s cell processing center; identified use cases and customer segments and developed unique value propositions\nJohn holds a Master and a Bachelor degree in Biomedical Sciences from University of Oxford.
URL:https://sapagp.org/event/cell-gene-therapy-cgt-rapid-growth-in-china-what-could-be-your-share-of-the-pie/
LOCATION:PA
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2021/07/July-15-Webinar-e1625185124573.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
END:VCALENDAR